Literature DB >> 19830454

Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003.

Alexandra Schifferli1, Rodo O von Vigier, Matteo Fontana, Giuseppina Spartà, Hans Schmid, Mario G Bianchetti, Christoph Rudin.   

Abstract

Hemolytic-uremic syndrome (HUS) is a leading cause of acute renal failure in childhood. In its typical presentation, it is preceded by an episode of diarrhea mostly due to Shiga-toxin-producing Escherichia coli. There is important geographical variation of many aspects of this syndrome. Nationwide data on childhood HUS in Switzerland have not been available so far. In a prospective national study through the Swiss Pediatric Surveillance Unit 114 cases (median age 21 months, 50% boys) were reported between April 1997 and March 2003 by 38 pediatric units (annual incidence 1.42 per 10(5) children < or =16 years). Shiga-toxin-producing E. coli were isolated in 32 (60%) of tested stool samples, serotype O157:H7 in eight. Sixteen children presented with only minimal renal involvement, including three with underlying urinary tract infection. Six patients presented with atypical hemolytic-uremic syndrome, and six with HUS due to invasive Streptococcus pneumoniae infection. Mortality was 5.3%, including two out of six children with S. pneumoniae infection. The severity of thrombocytopenia and the presence of central nervous system involvement significantly correlated with mortality. In conclusion, childhood HUS is not rare in Switzerland. Contrasting other countries, E. coli O157:H7 play only a minor role in the etiology. Incomplete manifestation is not uncommon.

Entities:  

Mesh:

Year:  2009        PMID: 19830454     DOI: 10.1007/s00431-009-1079-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Paucisymptomatic hemolytic uremic syndrome.

Authors:  R O von Vigier; N Offermann; B C Beretta-Piccoli; M G Bianchetti
Journal:  Pediatr Nephrol       Date:  2000-05       Impact factor: 3.714

2.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

3.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection.

Authors:  R I Hassink; S S Zeerleder; A C Truttmann; M G Bianchetti
Journal:  Pediatr Infect Dis J       Date:  1997-08       Impact factor: 2.129

4.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

Review 5.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

Review 6.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

7.  Acute community-acquired diarrhea requiring hospital admission in Swiss children.

Authors:  B Essers; A P Burnens; F M Lanfranchini; S G Somaruga; R O von Vigier; U B Schaad; C Aebi; M G Bianchetti
Journal:  Clin Infect Dis       Date:  2000-07       Impact factor: 9.079

8.  Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.

Authors:  Angela Gerber; Helge Karch; Franz Allerberger; Hege M Verweyen; Lothar B Zimmerhackl
Journal:  J Infect Dis       Date:  2002-08-02       Impact factor: 5.226

9.  Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience.

Authors:  Aoife M Waters; Larissa Kerecuk; David Luk; Mushfequr R Haq; Margaret M Fitzpatrick; Rodney D Gilbert; Carol Inward; Caroline Jones; Bruno Pichon; Christopher Reid; Mary P E Slack; William Van't Hoff; Michael J Dillon; C M Taylor; Kjell Tullus
Journal:  J Pediatr       Date:  2007-08       Impact factor: 4.406

Review 10.  Streptococcus pneumoniae-associated hemolytic uremic syndrome.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

View more
  19 in total

1.  Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center.

Authors:  Emilie Vallières; Maude Saint-Jean; Fabien Rallu
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

2.  Clinical Evaluation and Cost Analysis of Great Basin Shiga Toxin Direct Molecular Assay for Detection of Shiga Toxin-Producing Escherichia coli in Diarrheal Stool Specimens.

Authors:  Matthew L Faron; Nathan A Ledeboer; Jessica Connolly; Paul A Granato; Brenda R Alkins; Jennifer Dien Bard; Judy A Daly; Stephen Young; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

3.  Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome.

Authors:  Kathrin Buder; Beatrice Latal; Samuel Nef; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2014-09-19       Impact factor: 3.714

4.  Long-term health-related quality of life and psychological adjustment in children after haemolytic-uraemic syndrome.

Authors:  Helene Werner; Kathrin Buder; Markus A Landolt; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

5.  Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2014-08-21       Impact factor: 3.714

6.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection in humans: systematic review of the literature.

Authors:  Dejan Lavrek; Sebastiano A G Lava; Gregorio P Milani; Giacomo D Simonetti; Mario G Bianchetti; Olivier Giannini
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

7.  Health-related quality of life and mental health in parents of children with hemolytic uremic syndrome.

Authors:  Kathrin Buder; Helene Werner; Markus A Landolt; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2015-12-23       Impact factor: 3.714

8.  Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.

Authors:  Gianluigi Ardissino; Stefania Salardi; Elisa Colombo; Sara Testa; Nicolò Borsa-Ghiringhelli; Fabio Paglialonga; Valentina Paracchini; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Cristina Felice Civitillo; Stefano Sardini; Rossella Ceruti; Carlo Baldioli; Paola Tommasi; Luciana Parola; Fiorella Russo; Silvana Tedeschi
Journal:  Eur J Pediatr       Date:  2015-10-24       Impact factor: 3.183

9.  Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease.

Authors:  Laura F Alconcher; Alejandro Balestracci; Paula A Coccia; Angela Del C Suarez; Flavia B Ramírez; Marta L Monteverde; María Graciela Perez Y Gutiérrez; Paula M Carlopio; Illiana Principi; Patricia Estrella; Susana Micelli; Daniela C Leroy; Nahir E Quijada; Claudia Seminara; Marta I Giordano; Susana B Hidalgo Solís; Mariana Saurit; Alejandra Caminitti; Andrea Arias; Miguel Liern; Marta Rivas
Journal:  Pediatr Nephrol       Date:  2021-02-18       Impact factor: 3.714

Review 10.  Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine.

Authors:  Hemant S Agarwal; Samir Q Latifi
Journal:  Pathogens       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.